Cargando…

Comment on ‘The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy’

Detalles Bibliográficos
Autores principales:	Grzegorzewska, Agata M., Wiglusz, Mariusz S., Cubała, Wiesław J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150419/ https://www.ncbi.nlm.nih.gov/pubmed/37138781 http://dx.doi.org/10.1177/17562864231170934

Ejemplares similares

Dysphoria and Irritability—Diagnostic Pitfalls in the Assessment of Interictal Dysphoric Disorder in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

Multiple Comorbidity Profile of Psychiatric Disorders in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy
por: Shen, Sisi, et al.
Publicado: (2022)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals
por: Mechlińska, Agnieszka, et al.
Publicado: (2023)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports
por: Wilkowska, Alina, et al.
Publicado: (2019)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska, Alina, et al.
Publicado: (2021)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2023)

Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor
por: Cubała, Wiesław Jerzy, et al.
Publicado: (2010)

Cortisol awakening response in drug-naïve panic disorder
por: Jakuszkowiak-Wojten, Katarzyna, et al.
Publicado: (2016)

Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
por: Wilkowska, Alina, et al.
Publicado: (2022)

Effects of insomnia and levels of depression and anxiety symptoms on quality of life in people with epilepsy
por: Zhong, Rui, et al.
Publicado: (2022)

Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2021)

Depression and Anxiety in People with Epilepsy
por: Kwon, Oh-Young, et al.
Publicado: (2014)

Erratum: Depression and Anxiety in People with Epilepsy
por: Kwon, Oh-Young, et al.
Publicado: (2014)

Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review
por: Wilkowska, Alina, et al.
Publicado: (2020)

Anxiety, depression, and psychosocial adjustment in people with epilepsy
por: Jayalakshmi, Sita, et al.
Publicado: (2023)

Somatization Mediates the Structural Relationship of Alexithymia with Anxiety and Depression
por: Farhoumandi, Nima, et al.
Publicado: (2022)

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study
por: Szarmach, Joanna, et al.
Publicado: (2017)

Traumatic Life Events and Association With Depression, Anxiety, and Somatization Symptoms in Female Refugees
por: Moran, James Kenneth, et al.
Publicado: (2023)

Health anxiety in patients with depression with somatic symptoms and psychodermatological disorders
por: Ermusheva, A., et al.
Publicado: (2021)

Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
por: Włodarczyk, Adam, et al.
Publicado: (2023)

Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study
por: Włodarczyk, Adam, et al.
Publicado: (2021)

The Relationship between Depression, Anxiety, Somatization, Personality and Symptoms of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
por: Koh, Jun Sung, et al.
Publicado: (2015)

Somatic symptoms and their association with anxiety and depression in Chinese patients with cardiac neurosis
por: Zheng, Feng, et al.
Publicado: (2019)

Fatigue, Depression, and Anxiety in Patients with COPD, Asthma and Asthma-COPD Overlap
por: Homętowska, Henryka, et al.
Publicado: (2022)

The mediating effect of health anxiety in the relationship between functional somatic symptoms and illness behavior in Chinese inpatients with depression
por: Ma, Yue-Jiao, et al.
Publicado: (2019)

Health-Related Quality of Life, Depressive Symptoms, Anxiety, and Somatization Symptoms in Male and Female Patients with Chronic Tinnitus
por: Boecking, Benjamin, et al.
Publicado: (2021)

Somatic symptoms in depression
por: Kapfhammer, Hans-Peter
Publicado: (2006)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

Somatic symptoms mediate the association between subclinical anxiety and depressive symptoms and its neuroimaging mechanisms
por: Kong, Zhifei, et al.
Publicado: (2022)

Psychological factors: anxiety, depression, and somatization symptoms in low back pain patients
por: Bener, Abdulbari, et al.
Publicado: (2013)

The role of leptin in indirectly mediating “somatic anxiety” symptoms in major depressive disorder
por: Zhu, Yue, et al.
Publicado: (2022)

A cross-sectional study on the association of serum uric acid levels with depressive and anxiety symptoms in people with epilepsy
por: Zhong, Rui, et al.
Publicado: (2021)

Optimizing Care for Pregnancy in Epilepsy: The Need to Address Anxiety and Depression Symptoms
por: Munger Clary, Heidi M.
Publicado: (2023)

Gender Differences in Associated and Predictive Factors of Anxiety and Depression in People With Epilepsy
por: Liu, Zhao, et al.
Publicado: (2020)

The prevalence and predictive factors of somatization and its relationship with anxiety and depression in Iranian population
por: GARRUSI, B., et al.
Publicado: (2019)

Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy
por: Epps, S. Alisha
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_piq6r4rcq52d0114go4us2fdeb